US › Healthcare

Aclarion Inc (ACON)

US · Healthcare · Health Information Services

$2.64+3.53%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$25,208

Revenue YoY

+30.5%

Net profit

$-2.7M

EPS

$-1.12

EPS estimate

$-1.05

Net margin

-10,899.5%

EPS came in at -1.12 against a street estimate of -1.05 — a miss of 6.7%.

Key statistics

Market cap

$7.5M

Forward P/E

0.0

P/B

0.44

Book value

$6.91

EPS (TTM)

$-6.96

52-week high

$12.03

52-week low

$1.95

50-day MA

$2.51

200-day MA

$3.48

Beta

1.24

Analyst view

Analysts rate Aclarion Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $7.50.

Shareholding

Insiders

23.98%

Institutions

4.00%

Largest institutional holders

Fund	Stake
Advisor Group Holdings, Inc.	1.21%
Geode Capital Management, LLC	1.08%
CapTrust Financial Advisors	0.51%
Bank of Montreal	0.35%
BMO Capital Markets Corp.	0.35%
UBS Group AG	0.33%
Vanguard Capital Management, LLC	0.24%
Dauntless Investment Group, LLC	0.19%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aclarion Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.